Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice
Creator
Qiu, Chao
Chen, Hui
An, Jing
Fan, Dongying
Feng, Kaihao
Gao, Na
Sun, Jin
Wang, Ran
Zheng, Xiaoyan
Forrester, Naomi
An,
Cn, Jing
Khaiboullina, Svetlana
Xia, Jin
Xia, Jin Xjin@ips
Source
PMC
abstract
The development of a safe and effective tetravalent dengue vaccine that elicits protection against all dengue virus (DENV) serotypes is urgently needed. The consensus sequence of the ectodomain of envelope (E) protein of DENV (cE80) has been examined as an immunogen previously. In the current study, a cE80 DNA (D) vaccine was constructed and evaluated in conjunction with the cE80 protein (P) vaccine to examine whether both vaccines used together can further improve the immune responses. The cE80 DNA vaccine was administrated using either a homologous (DNA alone, DDD) or heterologous (DNA prime-protein boost: DDP or DPP) regimen, and evaluated for immunogenicity and protective efficacy in mice. Among the three DNA-based immunization regimens tested, DDP immunization is the optimal immunization regimen that elicited the greatest systemic immune response and conferred protection against all four DENV serotypes. This work provides innovative ideas for the development of consensus E-based dengue vaccines and the testing of optimal immunization regimens.
has issue date
2019-05-10
(
xsd:dateTime
)
bibo:doi
10.3389/fmicb.2019.01113
bibo:pmid
31134046
has license
cc-by
sha1sum (hex)
e09ca57e55d73869520543f456019ee081d88a00
schema:url
https://doi.org/10.3389/fmicb.2019.01113
resource representing a document's title
Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice
has PubMed Central identifier
PMC6524413
has PubMed identifier
31134046
schema:publication
Front Microbiol
resource representing a document's body
covid:e09ca57e55d73869520543f456019ee081d88a00#body_text
is
schema:about
of
named entity 'DENGUE VIRUSES'
named entity 'HETEROLOGOUS'
named entity 'DENV'
named entity 'envelope'
named entity 'consensus sequence'
named entity 'mice'
named entity 'DNA'
named entity 'DDP'
named entity 'serotypes'
named entity 'Viruses'
named entity 'PROTEIN '
named entity 'PROTECTION'
named entity 'ECTODOMAIN'
named entity 'CONSENSUS'
named entity 'SYSTEMIC'
named entity 'PREVIOUSLY'
named entity 'DNA VACCINE'
named entity 'DDD'
named entity 'VACCINE'
named entity 'DENGUE VACCINES'
named entity 'TESTED'
named entity 'USING'
named entity '28P'
named entity 'PROVIDES'
named entity 'IMMUNOGENICITY'
named entity 'CONSENSUS SEQUENCE'
named entity 'DNA'
named entity 'SEROTYPES'
named entity 'TESTING'
named entity 'IMMUNE RESPONSE'
named entity 'BOOST'
named entity 'DPP'
named entity 'EFFECTIVE'
named entity 'IMMUNE RESPONSES'
named entity 'CONJUNCTION'
named entity 'ELICITS'
named entity 'EFFICACY'
named entity 'TO EXAMINE'
named entity 'SAFE'
named entity 'PROTECTION'
named entity 'BASED'
named entity 'IMMUNOGEN'
named entity 'ADMINISTERED'
named entity 'EVALUATED'
named entity 'IMMUNE RESPONSES'
named entity 'REGIMEN'
named entity 'SEQUENCE'
named entity 'CONSENSUS'
named entity 'MICE'
named entity 'ECTODOMAIN'
named entity 'OPTIMAL'
named entity 'STUDY'
named entity 'PROTEIN '
named entity 'DEVELOPMENT'
named entity 'DENGUE VIRUS'
named entity 'IDEAS'
named entity 'EXAMINED'
named entity 'DDP'
named entity 'CONSTRUCTED'
named entity 'NEEDED'
named entity 'HOMOLOGOUS'
named entity 'GREATEST'
named entity 'SINGLE'
named entity 'ENVELOPE PROTEIN'
named entity 'USED'
named entity 'PRIME'
named entity 'EITHER'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 11
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software